The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains.
Hay, D., Fedorov, O., Filippakopoulos, P., Martin, S., Philpott, M., Picaud, S., Hewings, D.S., Uttakar, S., Heightman, T.D., Conway, S.J., Knapp, S., Brennan, P.E.(2013) Medchemcomm 4: 140-144
- PubMed: 26682033 
- DOI: https://doi.org/10.1039/C2MD20189E
- Primary Citation of Related Structures:  
4GPJ - PubMed Abstract: 
Simple 1-substituted 5- and 6-isoxazolyl-benzimidazoles have been shown to be potent inhibitors of the BET bromodomains with selectivity over the related bromodomain of CBP. The reported inhibitors were prepared from simple starting materials in two steps followed by separation of the regioisomers or regioselectively in three steps.
Organizational Affiliation: 
Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.